科兴制药股价跌5.03%，华泰保兴基金旗下1只基金重仓，持有2.1万股浮亏损失4.28万元

Group 1 - The core point of the news is that Kexing Pharmaceutical's stock price has dropped by 5.03%, currently trading at 38.50 yuan per share, with a total market capitalization of 7.748 billion yuan [1] - Kexing Biopharmaceutical Co., Ltd. is primarily engaged in the research, production, and sales of recombinant protein drugs and micro-ecological preparations, with 97.38% of its revenue coming from pharmaceutical products [1] - The company was established on August 22, 1997, and went public on December 14, 2020 [1] Group 2 - Huatai Baoxing Fund holds a significant position in Kexing Pharmaceutical, with its Huatai Baoxing Kexing A fund (009124) owning 21,000 shares, representing 1.59% of the fund's net value [2] - The fund has experienced a floating loss of approximately 42,800 yuan today [2] - The fund was established on May 11, 2020, and has a current scale of 20.8067 million yuan, with a year-to-date return of 7.86% [2] Group 3 - The fund managers of Huatai Baoxing Kexing A are Zhou Yongmei and Chen Qiwei, with Zhou having a tenure of 7 years and 232 days and Chen having a tenure of 2 years and 98 days [3] - Zhou's fund has a total asset scale of 8.897 billion yuan, with the best return during her tenure being 43.64% [3] - Chen's fund has a total asset scale of 24.594 billion yuan, with the best return during his tenure being 18.95% [3]